Itau Unibanco Holding S.A.’s TG Therapeutics TGTX Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-122	Closed	-$2.17K	–	424
2024 Q2	$2.17K	Buy	+122	New	+$1.95K	﹤0.01%	336
2024 Q1	–	Sell	-190	Closed	-$3.25K	–	336
2023 Q4	$3.25K	Sell	190 -34	-15%	-$395	﹤0.01%	356
2023 Q3	$1.87K	Sell	224 -4	-2%	-$56	﹤0.01%	465
2023 Q2	$5.66K	Buy	+228	New	+$5.89K	﹤0.01%	487
2021 Q4	–	Sell	-407	Closed	-$14K	–	474
2021 Q3	$14K	Buy	407 +10	+3%	+$309	﹤0.01%	355
2021 Q2	$15K	Buy	+397	New	+$15.6K	﹤0.01%	318

Other funds holding TGTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Itau Unibanco Holding S.A.'s TGTX Position: Q3 2024 in Review

Itau Unibanco Holding S.A. sold out of TG Therapeutics (TGTX) in Q3 2024, closing a stake of 122 shares — an estimated $2.17K sold.

Itau Unibanco Holding S.A. first reported a position in TGTX in Q2 2021 and held it in 6 quarters. The position peaked at $15K in Q2 2021. 308 funds tracked by Wall St. Rank hold TGTX as of Q3 2024.

Itau Unibanco Holding S.A. reported no remaining TG Therapeutics position as of Q3 2024 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 122 TG Therapeutics shares in Q3 2024, an estimated $2.17K.
Itau Unibanco Holding S.A. first reported a position in TG Therapeutics in Q2 2021 and held it in 6 quarters.
Itau Unibanco Holding S.A.'s TG Therapeutics position peaked at $15K in Q2 2021.
308 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2024, filed 14 Nov 2024.